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ABSTRACT Two factors that interact specifically with the
chromosomal replicator, autonomously replicating sequence 1
(ARSI), were identified in whole-cell yeast extracts. One of
these proteins, ARS binding factor I (ABF-I), was purified to
homogeneity as a polypeptide of 135 kDa. ABF-I binds within
a region previously shown to be essential for the function of
ARSI when yeast are grown under certain nutritional condi-
tions, and deletion analysis presented here suggests that the
ARSI domain containing the ABF-I-binding site, domain B, is
a complex element composed of at least two subdomains.
ABF-I also binds within an ARS at the HMR silent mating
locus. This ARS functions as a cis-acting transcriptional
silencer, and the ABF-I-binding site within this ARS is impor-
tant for both ARS and silencer function.
For example, a sequence within domain B that contains the
binding site for the protein here described was essential for
ARS function when galactose was the primary carbon
source, but this sequence appeared less important when
glucose was the primary carbon source (12).
Origin-specific DNA binding proteins are important com-
ponents of most prokaryotic and eukaryotic viral replication
systems (14-24). Interestingly, in addition to being required
for DNA replication, they can often exert either positive or
negative effects on transcription (24-29). Because specific
DNA sequences are required for ARS function, proteins that
bind specifically to these sequences probably have a role in
eukaryotic DNA replication. In this paper we describe two
DNA-binding factors that interact specifically with ARS).
Eukaryotic DNA replication initiates from multiple origins
once and only once during a discrete part of the cell cycle S
phase. Both the number of origins used and the temporal
activation of origins during S phase can vary enormously in
response to conditions such as developmental state (1, 2).
The molecular mechanism by which eukaryotic chromo-
somal DNA replication initiates is at present not known;
however, the direct demonstration that autonomously repli-
cating sequences (ARS) in the yeast Saccharomyces cerevi-
siae act in vivo as origins of replication (3-5) provides an
experimental system to study chromosomal DNA replica-
tion.
Sequence requirements for ARS function suggest that
eukaryotic origins of replication are complex (6-10). All
ARSs contain and absolutely require the ARS core consen-
sus sequence (WTTTATRTT1'W; where W = A or T and R
= purine), which alone is insufficient for efficient ARS
activity. Sequences flanking the core are important for ARS
function, and functional redundancy often appears in these
flanking sequences. ARSJ is located at the 3' end of the
TRPJ gene and has been shown by deletion analysis to
consist of three functional domains designated A, B, and C
(6). Domain A contains the ARS core sequence and is
essential for ARSJ function. Domain B is an 84-base-pair
(bp) region located 29 bp 3' to the ARS core sequence and is
extremely important for efficient ARS activity. Recently,
this domain was shown to contain a binding site for a protein
identified in crude extracts (11), which overlaps both a
region of bent DNA (12) and a sequence conserved among
many ARSs (13). Domain C is located further than 100 bp 5'
to the ARS consensus sequence and has a smaller effect on
ARS) function. Domains B and C are functionally redundant
because domain A will function with either domain B or C,
although domain B appears to be more efficient in this
capacity (6). Furthermore, deletion analysis within domain B
indicates that it may contain distinct functional elements.
MATERIALS AND METHODS
Strains and DNAs. The yeast strain used for the identifi-
cation and purification of ARS binding factors I and II
(ABF-I and ABF-II) was a protease-deficient strain BJ 1991
(Mata leu2 ura3 trpl prbl-1122 pep4B) from R. Kostriken
(Cold Spring Harbor Laboratory).
The Rsa I [nucleotide (nt) 927)J-HindIII (nt 616), the Rsa
I (nt 927)-Pst I (nt 827), and the Rsa I (nt 927)-Hinfl (nt 734)
fragments of ARS) (see Fig. 5) were subcloned into pUC19
(30) to yield pARS1.2, pARS1.3, and pARS1.4.1, respec-
tively. A pARS1.4.1 fragment containing ARS) sequences
was excised with EcoRI and HindIII for use in DNA-binding
assays. Bal-31 deletions were generated in domain B from
either the HindIII site in the plasmid vector polylinker (AH
series) or the Bgl II site at nt 854 (AB series) of pARS1.4.1.
The HindIII site in the AH series and the Bgl II site in the AB
series were replaced with HindIII or Bgl II linkers, respec-
tively. These domain-B deletions contained on a Hin-
dIII-Bgl II fragment were then used to replace wild-type
domain B in pARS1.4.1. To invert domain B with respect to
domain A (pARS1.4.1), the Bgl II (nt 854)-BamHI (pUC
polylinker) fragment was cut out of pARS1.4.1, religated,
and recut with Bgl II and BamHI to eliminate religation in
the wild-type orientation before transformation. The pARS-
1.7 series was constructed by ligating random, total Sau3A-
digested pBR322 into the Bgl II site of pARS1.4.1. The
EcoRI-HindIII fragment containing wild-type domain A and
mutated domain B was then inserted into yeast plasmid
YRpl4/CEN4 between the unique EcoRI and HindIII sites
for use in the colony color assay described by Hieter et al.
(31).
DNA-Binding Assay. DNA-binding reactions were formu-
lated as described using 10-20 ng of labeled DNA probe (32)
and subjected to electrophoresis in low-ionic-strength poly-
Abbreviations: ARS, autonomously replicating sequence; ABF-I
and ABF-II proteins, ARS binding factors I and II; SBF-B, silencer
binding factor B; HMRE, ARS at E region of HMR silent mating
type locus; AH and AB, deletions generated from HindIII site or Bgl
II site, respectively.
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acrylamide gels essentially as described (33). DNase I "foot-
printing" (34) was done as described (32) without added
competitor DNA. Recovery and renaturation of ABF-I from
NaDodSO4/polyacrylamide gels (35) was essentially by the
method of Hager and Burgess (36). Silver staining of Na-
DodSO4/polyacrylamide gels was by the method of Oakley
et al. (37).
Preparation of Extracts and Purification of ABF-I. Cells
were grown to late logarithmic phase at 300C in yeast extract/
peptone/dextrose (YPD) medium, harvested by centrifuga-
tion, resuspended in cold phosphate-buffered saline, har-
vested again, and stored at -700C. Cells from 36 liters of
yeast were thawed in 2-3 volumes of buffer X [50 mM Pipes
(piperazinediethanesulfonate)/10 mM sodium metabisulfite/1
mM phenylmethylsulfonyl fluoride/10 mM dithiothreitol/1
mM EDTA/20%o (vol/vol) glycerol] and disrupted in a bead
beater (Biospec Products, Bartlesville, OK) with an equal
volume of acid-washed glass beads in 10 30-sec bursts.
Extracts were diluted to 0.2 M (NH4)2SO4 with 4 M stock.
After 30 min on ice, cell debris was removed by centrifugation
at 10,000 x g for 20 min. Conductivity was adjusted to 160
mM (NH4)2SO4 with buffer X and loaded onto a column of
heparin-agarose (38) (4 x 18 cm) in buffer X containing 160
mM (NH4)2SO4. The column was washed with 200 ml of
buffer X containing 160 mM (NH4)2SO4 and developed with a
1.5-liter linear gradient from 160 to 500 mM (NH4)2SO4 in
buffer X. ABF-I and ABF-II DNA-binding activities eluted at
-300 mM (NH4)2SO4. Active fractions were combined, ad-
justed to 300 mM (NH4)2SO4, and loaded onto a column of
Blue Sepharose CL-6B, Pharmacia (2.2 x 6 cm) in buffer X
containing 300 mM (NH4)2SO4. The column was washed with
50 ml of buffer X containing 300 mM (NH4)2SO4. These
fractions contain all the ABF-I activity. The column was
subsequently washed with 50 ml of buffer X/1.0M NaCl, and
ABF-II was eluted with 50 ml of buffer X/2.5 M NaCl/5%
Triton X-100. The ABF-I fraction was adjusted to 1.0 M
(NH4)2SO4 and loaded onto a phenyl-Sepharose CL4B col-
umn (3 x 8 cm; Pharmacia) in buffer X containing 1 M
(NH4)2SO4. The column was washed with 50 ml of buffer X
containing 0.5 M (NH4)2SO4, and ABF-I was eluted with a
500-ml linear gradient from 0.5 to 0.0 M (NH4)2SO4 in buf-
fer X. ABF-I elutes in a broad peak centered at 400 mM
(NH4)2SO4. Active fractions were combined and dialyzed
against buffer X containing 50 mM NaCl. ABF-I was loaded
onto a denatured calf thymus DNA cellulose column (39) (2.2
x 5 cm) equilibrated in buffer X containing 50 mM NaCl. The
column was washed with 20 ml of buffer X containing 50 mM
NaCl, and ABF-I was eluted at 160 mM NaCI with an 80-ml
linear gradient from 50 to 350 mM NaCI in buffer X. Active
fractions were dialyzed overnight against buffer X containing
500 mM NaCI and 30%o (wt/vol) sucrose and loaded (5 ml)
onto a Sephacryl S-300 column (2 x 90 cm; Pharmacia) in
buffer X containing 500 mM NaCl; the column was run at 10
ml/hr, and 2.5-ml fractions were collected. Active fractions
were dialyzed overnight against buffer X and loaded onto a
Mono Q 5/5 column (Pharmacia) in buffer X, washed with 3
ml of buffer X containing 80 mM NaCl, and eluted with a
10-ml linear gradient from 80 to 350 mM NaCl in buffer X.
Active fractions were combined, aliquoted, and stored at
- 700C.
RESULTS
ARSI-Specific DNA-Binding Activities. ARS1 specific
DNA-protein complexes were identified after electrophore-
sis through low-ionic strength polyacrylamide gels (33) using
a modification of the DNA-binding reactions previously
described (32). In Fig. 1, a crude whole-cell extract from late
logarithmic phase yeast was titrated into reactions contain-
ing constant amounts of unlabeled competitor DNA and
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FIG. 1. Detection of ARSI-specific DNA-protein ijiteractions
with a crude whole-cell extract by gel retention analysis. Whole-cell
yeast extract was titrated into DNA-binding reactions formulated
and processed as described. Labeled DNA was either the EcoRI-
HindIII fragment from pARS1.4.1 that contains domains A and B of
ARSI (A) or the BamHI-Sal I fragment from pBR322 (B).
labeled probe-either a fragment containing domains A and
B from ARSJ (Fig. LA) or an equal-sized fragment from
pBR322 (Fig. 1B). Two DNA-protein complexes formed
with ARSI DNA and absent from equivalent positions in the
pBR322 lanes were evident and were designated accordingly
ABF-I and -II. Purification and characterization of ABF-I is
presented here. Purification and characterization of ABF-Il,
which interacts specifically with ARSI DNA, will be re-
ported elsewhere.
Interaction of ABF-I with Other ARSs. A number of
well-characterized ARSs were screened for ABF-I binding
sites by testing the ability of linear plasmids containing these
ARSs to compete with labeled ARS1 DNA for binding of
partially purified ABF-I. Fig. 2 summarizes these results. Of
the six ARSs tested (Fig. 2) and ARS2 and HML silent
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FIG. 2. Competition of the ABF-I-ARSI complex by other
ARSs. A partially purified fraction of ABF-I equivalent to the
denatured DNA cellulose fraction was added to reactions formu-
lated as described containing additional varying amounts of linear-
ized plasmids (from 3 to 8.5 kilobases in size); pARS1.2 (o), pBR322(*), YRpl4/CEN4/histone H4 ARS (o), YRpl4/CEN4/histone
H2B ARS (i), the HindIII fragment containing HMR in pBR322 (A),
and YEp213 (2-,um origin of replication) (A). Bands corresponding to
the ABF-I-ARSI complex were excised from gels after autoradio-
graphy, and amounts of radioactivity in the complex were quanti-
tated by liquid scintillation counting. Results are plotted as % of
ABF-I-ARSI complex without plasmid competitor.
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mating type cassette (data not shown), only the HMR silent
mating type cassette, which has ARS activity, could compete
with ARSJ efficiently and therefore must contain at least one
ABF-I binding site. A high-affinity ABF-I binding site at
HMR was subsequently localized with purified ABF-I (see
below).
Purification of ABF-I. The purification procedure de-
scribed in Materials and Methods was developed to purify
ABF-I to homogeneity. ABF-I and ABF-II cochromato-
graph during the first step, heparin-agarose, which results in
a 50- to 100-fold purification, and these activities were
subsequently separated by Blue Sepharose chromatography.
ABF-I was further purified as described above to yield =5
pg of homogeneous protein from 36 liters [=600 g (wet
weight) of cells] of yeast in late-logarithmic phase. Although
accurate measurement of DNA-binding activity in the rela-
tively crude fractions is difficult, we estimate roughly a
30,000- to 50,000-fold purification based on specific activity.
In Fig. 3 A and B a Mono Q column profile is shown. The
elution of a 135-kDa polypeptide as judged by silver-stained
NaDodSO4/PAGE (Fig. 3B) corresponds exactly with the
elution of ARSJ-specific DNA-binding activity (Fig. 3A),
arguing strongly that the 135-kDa polypeptide is the active
ABF-I protein. To demonstrate this point unambiguously,
the 135-kDa polypeptide was recovered from a preparative
NaDodSO4/polyacrylamide gel and renatured. The gel-
purified and renatured 135-kDa polypeptide formed a com-
plex with ARSI DNA that migrated through low-ionic strength
nondenaturing gels at an identical position to authentic ABF-I
activity from the Mono Q fraction (Fig. 3C). Approximately
30% of the ABF-I activity could be recovered in pilot denatu-
ration-renaturation experiments without gel isolation (Fig. 3C,
lane 3), and at least half of that could be recovered after gel
isolation of the 135-kDa polypeptide. Furthermore, plasmids
containing ARS) and HMR (Fig. 3C, lanes 8 and 11) but not
vector (pBR322) or plasmids containing ARS2, HML, histone
H4 ARS, histone H2B ARS or the 2-pum origin of replication
(lanes 7, 9, 10, 12-14) could compete with labeled ARSI DNA
for binding of the renatured protein. Therefore, ABF-I-binding
activity resides in the 135-kDa polypeptide.
ABF-I-Binding Sites at ARSI and HMR. DNase I footprint-
ing with purified ABF-I was used to locate and define the
ABF-I-binding sites at ARSI and HMR (Fig. 4). This anal-
ysis demonstrates that ABF-I binds to a single site in ARSI
at the distal end of domain B and also at a single site in the
ARS associated with HMR E region (HMRE). In Fig. 4B,
the location and nucleotide sequence of the ABF-I binding
sites at ARSI and HMRE is depicted.
Functional Analysis of Domain B. The ABF-I-binding site
at ARSI is essential when yeast were grown in medium
containing galactose (12). We have examined the effect of
mutations within domain B on ARSI activity on medium
containing glucose. Plasmid stability was measured as per-
cent of plasmid lost per generation using the colony color
assay described by Hieter et al. (31) used to indicate ARS
strength. These results are summarized in Fig. 5. Domains A
and B in the absence of domain C (pARS1.4.1) are lost at a
rate of "-10% per generation compared with 5% loss per
generation for the wild-type ARSl (data not shown). Dele-
tion of domain B (pARS 1.3) results in a plasmid that exhibits
an extremely high degree of instability, confirming the
crucial role of domain B in ARSI function (6). The AH5
mutation, which deletes to nt 754 and is unable to bind ABF-
I (data not shown), exhibited a small, but significantly
decreased stability, when compared with wild-type domains
A and B. Because this decrease in stability is considerably
less than the decrease exhibited by the complete deletion of
domain B, this domain appears to have at least two definable
elements. One element contains the ABF-I-binding site and
under these conditions has a small role in ARS function,
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FIG. 3. Fast protein liquid chromatography Mono Q chroma-
tography ofABF-I. (A) One-tenth microliter of the Mono Q fractions
indicated was assayed for ARSI-specific DNA-binding activity as
described. (B) Ten microliters of the fractions indicated were run on
a 10%o polyacrylamide gel in NaDodSO4 and stained with silver. Mr
markers are myosin (200 kDa), /3-galatosidase (116 kDa), phos-
phorylase b kinase (92 kDa), bovine serum albumin (68 kDa), and
ovalbumin (45 kDa). (C) Approximately 0.5 ,ug of the Mono Q
fraction of ABF-I was fractionated by NaDodSO4/PAGE as above
and stained with 0.25 M KCI (39). The 135-kDa polypeptide was cut
from the gel, eluted, and renatured as described. Fractions were
assayed for DNA-binding activity as described. Lanes: 1, no added
protein; 2, 0.5 1.l of the Mono Q fraction of ABF-I; 3, 1 pl of this
fraction denatured and renatured without PAGE fractionation; 4-6,
1, 3, and 5 1.l of gel-isolated renatured 135-kDa polypeptide, respec-
tively; 7-14, 5 ,ul of gel-isolated renatured 135-kDa polypeptide with
0.1 ,ug of linearized pBR322, pARS1.2, YRpl4/CEN4/ARS2, HML,
HMR, YRpl4/CEN4/histone H4 ARS, YRpl4/CEN4/histone H2B
ARS, and YEp213, respectively.
whereas the other element containing sequences between
the ABF-I-binding site and domain A has a dominant role in
ARS function. The internal deletions AB3 and AB5 that
remove nucleotides 818-852 and 783-852, respectively, also
have severe effects on ARS function. Although insertion or
deletion of 4 bp at the Bgl II site separating domains A and
B had no effect on ARS activity, either insertion of any
random pBR322 DNA from 195 to 1080 bp into this site or
inversion of domain B with respect to domain A at this site
completely inactivated domain B. Domain B function is,
therefore, both orientation- and position-dependent with re-
spect to domain A.
DISCUSSION
Two ARSJ-specific DNA-binding factors (ABF-I and ABF-
II) have been identified in crude extracts. These proteins are
Proc. Natl. Acad. Sci. USA 85 (1988)
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FIG. 4. DNase I footprinting of ABF-I at ARSJ and HMR. (A)
DNA fragments for footprinting were 5' end-labeled with polynu-
cleotide kinase by standard procedures, and footprinting reactions
were done as described with S ng of the Mono Q fraction of ABF-I.
For footprinting ARSI, the EcoRI-HindIII fragment of pARS1.2
was used, 5' end-labeled at either the HindIII (ARSI top) or EcoRI
(ARSI bottom) site. For footprinting at HMR, either pJA82.6A173
(HMRE top) or pJA82.6A&224 (HMRE bottom) linker scanning
mutants labeled at the unique Xho I linker insertion site were used
(35). Alongside each footprint is a diagram of each region with se-
quence features aligned as on sequencing gel. Hatched region
represents ABF-I-binding site. The three groups of gels at left are
5%, and the HMRE bottom gel (at right) is 12.5% 8 M urea
sequencing gel. (B) Positions and base-pair sequences of the ABF-
I-binding sites (hatched regions) at ARSI and HMRE with sequence
features of these two regions (depicted to scale). The functional A
and B domains at ARSI, and the A, E, and B elements at HMR were
previously described (20, 37). Stippled regions, location of the ARS
core consensus sequence at these two ARSs. Arrows, extent of the
ABF-1 footprint. For optimal comparison to the ARSI-ABF-I
binding site, HMRE site should be inverted.
ARSI-specific by virtue of the fact that they form complexes
with ARSJ DNA, whereas equivalent complexes are not
formed with pBR322 DNA. One of these proteins, ABF-I,
has been purified to homogeneity by conventional chroma-
tography as a polypeptide of 135 kDa. The other protein,
ABF-II, has been purified as a 21-kDa protein that interacts
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FIG. 5. Analysis of domain B function. ARSI derivatives were
constructed as described and are depicted. The percent plasmid loss
per generation was determined by the half-sector method described
by Hieter et al. (31). Regions deleted are indicated by gaps, vector
sequences are indicated by thin lines, functionally important do-
mains of ARSI (A and B) (6, 7) are shown as boxes, and other yeast
sequences in ARSI are denoted by thick lines. The ABF-I-binding
site in domain B is indicated by a hatched box, and the position of
inserts in the pARS1.7 series is denoted by the wavy line. Final
number in plasmid names of pARS1.7 series indicates size of in-
serted DNA.
specifically at multiple sites in ARSJ and will be reported
elsewhere.
Competition analysis with seven of the best-characterized
ARSs revealed that ABF-I is not a universal ARS-binding
factor. However, this protein binds specifically to both
ARSJ and an ARS at the HMR silent mating type locus
(HMRE) at sites that are important for the efficient function
of these ARSs and suggests that ARSJ and HMRE are
members of a functionally related subset of all ARSs. The
ABF-I-binding site at ARS) lies within domain B, an 84-bp
region previously shown to be important for ARSI function.
Snyder et al. (12) showed by deletion analysis that the
ABF-I-binding site, which overlaps a region of bent DNA, is
essential for ARS function when the primary carbon source
for growth is galactose. In agreement, we demonstrate that a
similar deletion exhibits only a small effect on ARSJ func-
tion when the primary carbon source for growth is glucose,
whereas deletion of the rest of domain B still has a profound
effect on ARSI function. Taken together, these results sug-
gest that domain B is a complex sequence element, the
function of which is both position and orientation dependent
with respect to domain A and which is composed of at least
two subdomains. Although a function of the ABF-I-binding
site could be to regulate specifically ARSJ function under
certain growth conditions, more probably all ARSs function
less well on poor carbon sources, where the differences
between "weak" and "strong" ARSs are more pronounced.
The role of the ABF-I-binding site in function of the HMRE
ARS is more clear. Small insertion/deletions that remove
the ABF-I binding site from HMRE profoundly decrease
mitotic stability of plasmids containing HMRE, perhaps by
reducing efficient replication of these plasmids (40).
HMRE, besides being an ARS element, is also required
for repression of transcription of the mating type information
contained at this locus (41, 42). HMRE can silence transcrip-
tion in a position- and orientation-independent manner, and
the silencer can function on heterologous promoters (42).
The HMRE region itself has been further divided into three
functional elements, A, E, and B (40) and it is within one of
these, element B, that ABF-I binds. Importantly, there is
functional redundancy among these elements because dele-
tion of any one has little or no effect on silencer function,
whereas deletion of any two elements completely inactivates
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the silencer (40). These three elements alone are sufficient
for ARS activity, and the functional overlap between ele-
ments required for silencing and ARS activity is striking.
Element A contains the ARS consensus sequence and is
essential for ARS activity on small cloned fragments con-
taining these three elements (40). Recently, Shore et al. (11)
identified two proteins in crude extracts designated silencer
binding factors B and E (SBF-B and SBF-E) that interact
with elements B and E, respectively. SBF-B, in addition to
binding at HMRE, also binds to ARSJ within domain B, and
the binding sites for both ABF-I and SBF-B at these two
ARSs appear to be equivalent, although the potential iden-
tity of ABF-I and SBF-B awaits further characterization of
SBF-B. In addition to importance for HMRE ARS function
(see above), the ABF-I/SBF-B binding site becomes essen-
tial for silencer function in the absence of either the A or E
elements, suggesting that ABF-I may have a role in both
DNA replication and repression of transcription. Although
the molecular mechanism of silencing is not understood, it is
intriguing that silencer activity is so closely correlated with
ARS function, particularly since reestablishment of the
repressed transcriptional state at the silent mating type loci
depends upon a round of DNA replication (43).
Because the HMRE silencer can function at either the 5'
or 3' end of genes on any promoter (including the TRPJ
promoter) (42) and with the A and B elements alone (40), it
is tempting to speculate that ARS), by virtue of its similarity
to HMRE, may have a role in repressing TRPJ transcription.
As for other replication origins (21, 24, 40), the relationship
between transcription and replication at TRPI-ARSJ may
prove quite interesting.
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